References
- Bertilsson L., Thomson T. Kinetics and metabolism of carbamazepine 10,11‐epoxide in man. Metabolism of Antiepileptic Drugs, R. H. Levy, M. Eichelbaum, W. Pitlick, J. Meijer. Raven Press, New York 1984; 19–25
- Bertilsson L., Tomson T., Tybing G. Pharmacokinetics: time‐dependent changes—autoinduction of carbamazepine epoxidation. Journal of Clinical Pharmacology 1986; 26: 459–462
- Breimer D. Variability in human drug metabolism and its implications. International Journal of Clinical Pharmacology Research 1983; 3: 399–412
- Campbell M., Spielberg S., Kalow W. A urinary metabolite ratio that reflects systemic caffeine clearance. Clinical Pharmacology and Therapeutics 1987; 42: 157–165
- Chan K., Sawchuk R., Thompson T., Redalieu E., Wagnep W., Jr, Lesher A., Weeks B., Hall N., Gerardin A. Bioequivalence of carbamazepine chewable and conventional tablets: single‐dose and steady‐state studies. Journal of Pharmaceutical Sciences 1985; 74: 866–870
- Conney A. H. Pharmacological implications of microsomal enzyme induction. Pharmacological Reviews 1967; 19: 317–366
- Eichelbaum M., Tomson T., Tybring G., Bertilsson L. Carbamazepine metabolism in man: Induction and pharmacogenetic aspects. Clinical Pharmacokinetics 1985; 10: 80–90
- Gelboin H. Benzo(a)pyrene metabolism, activation, and carcinogenesis: Role and regulation of the mixed‐function oxidases and related enzymes. Physiological Reviews 1980; 60: 1107–1166
- Hepner G., Vesell E. Assessment of aminopyrine metabolism in man by breath analysis after oral administration of ‘14C’‐aminopyrine. New England Journal of Medicine 1974; 291: 1384–1388
- Inaba T., Tang B., Endrenyi L., Kalow W. Amobarbital—a probe of hepatic drug oxidation in man. Clinical Pharmacology and Therapeutics 1976; 20: 493–444
- Mackichan J. Carbamazepine. A Textbook for the Clinical Application of Therapeutic Drug Monitoring 36, W. J. Taylor, Mary Diers Caviness. Abbott Laboratories. 1986; 211–224
- Nebert D., Gonzalez F. P‐450 genes: structure, evolution, and regulation. Annual Reviews of Biochemistry 1987; 56: 945–993
- Park B. In vivo probes for drug metabolizing enzymes. Drug Metabolism—from Molecules to Man, D. J. Benford, J. W. Bridges, G. G. Gibson. Taylor & Francis, London 1987; 285–296
- Paxton J., Donald R. Concentrations and kinetics of carbamazepine in whole saliva, parotid saliva, serum ultrafiltrate, and serum. Clinical Pharmacology and Therapeutics 1980; 28: 695–702
- Rambeck B., May T., Juergens U. Serum concentrations of carbamazepine and its epoxide and diol metabolites in epileptic patients: The influence of dose and comedication. Therapeutic Drug Monitor 1987; 9: 298–303
- Sheiner L., Beal S. Some suggestions for measuring predictive performance. Journal of Pharmacokinetics and Biopharmacology 1981; 9: 503–512
- Shumaker R. PKCALC: A BASIC interactive computer program for statistical and pharmacokinetic analysis of data. Drug Metabolism Reviews 1986; 17: 331–348
- Sjoovist G. Interindividual differences in drug responses: an overview. Variability in Drug Therapy: Description, Estimation, and Control, M. Rowland, L. Sheiner, J. Steimer. Raven Press, New York 1985; 1–9
- Vesell E. Genetic and environmental factors affecting drug disposition in man. Clinical Pharmacology and Therapeutics 1977; 22: 659–679
- Vesell E. The antipyrine test in clinical pharmacology: conceptions and misconceptions. Clinical Pharmacology and Therapeutics 1979; 26: 275–286